source
- NEJM retracts pivotal data for Amgen's Tavneos, adding new hurdle for the autoimmune drugThe New England Journal of Medicine has withdrawn the pivotal data that supported Amgen’s autoimmune therapy Tavneos. The retraction was requested by two academic authors who raised concerns about…
- FDA’s top gene-therapy regulator Vijay Kumar steps down amid leadership shake-upVijay Kumar, the acting director of the FDA office that reviews cell and gene therapies, has announced he will leave his position. In an email to staff, Kumar said he reflected on his tenure and de…